Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN was delisted on the 3rd of October, 2022.
7 hedge funds and large institutions have $13.8M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 229 closing their positions.
97% less funds holding in top 10
Funds holding in top 10: 32 → 1 (-31)
97% less funds holding
Funds holding: 240 → 7 (-233)
99% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 229
100% less capital invested
Capital invested by funds: $8.78B → $13.8M (-$8.77B)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$9.87K |
| 2 |
MSCM
McElhenny Sheffield Capital Management
Dallas,
Texas
|
+$4.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$748M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$572M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$537M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$464M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$349M |
BHVN Hedge Fund Activity: Q4 2022 in Review
7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q4 2022, worth a combined $13.8M — down 100% from $8.78B a quarter earlier.
Sellers outnumbered buyers: 229 funds closed out of BHVN and 2 opened new positions — a net loss of 227 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Blue Trust Inc, opening a new position worth an estimated $9.87K. The largest seller was BlackRock, exiting entirely with an estimated $748M sold.
- 7 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q4 2022, down from 240 in Q3 2022.
- Funds reported $13.8M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q4 2022, down 100% quarter-over-quarter.
- 2 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q4 2022 and 229 closed out, a net change of -227 holders.
- The largest Biohaven Pharmaceutical Holding Company Ltd. buyer in Q4 2022 was Blue Trust Inc, an estimated $9.87K added.
- The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q4 2022 was BlackRock, an estimated $748M sold.
Based on aggregated 13F filings for Q4 2022.